Literature DB >> 8880165

Outcome measurement in economic evaluation.

M Johannesson1, B Jönsson, G Karlsson.   

Abstract

Mesh：

Year:  1996        PMID： 8880165     DOI： 10.1002/(SICI)1099-1050(199607)5:4<279::AID-HEC218>3.0.CO;2-J

Source DB:  PubMed          Journal:  Health Econ        ISSN： 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  33 in total

Review 1.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  [Cost-benefit analysis in health care].

Authors:  J Puig-Junoy; J L Pinto-Prades; V Ortún-Rubio
Journal:  Aten Primaria       Date:  2001-04-15       Impact factor: 1.137

Review 3.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

4.  Measurement of short term health effects in economic evaluations.

Authors:  A M Holmes
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

Review 5.  The development and use of quality-of-life measures to evaluate health outcomes in Japan.

Authors:  Shunichi Fukuhara; Naoki Ikegami; George W Torrance; Shuzo Nishimura; Michael Drummond; François Schubert
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms.

Authors:  Yvonne Anne Michel; Liv Ariane Augestad; Mathias Barra; Kim Rand
Journal:  Qual Life Res       Date:  2018-11-30       Impact factor: 4.147

7.  Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

Authors:  David K Whynes; Emma J Frew; Jane L Wolstenholme
Journal:  Int J Health Care Finance Econ       Date:  2005-12

8.  The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.

Authors:  Sinaa A Al Aqeel; Mohammed Al-Sultan
Journal:  Saudi Pharm J       Date:  2011-12-24       Impact factor: 4.330

9.  Indirect costs in ambulatory patients with HIV/AIDS in Spain: a pilot study.

Authors:  Juan Oliva; César Roa; Juan del Llano
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement.

Authors:  R Jake Jacobs; Ronald J Moleski; Allen S Meyerhoff
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.